|Podcasts|December 21, 2020

The growing role of remote patient monitoring devices

What has the COVID-19 pandemic taught us about the role of remote monitoring devices in helping doctors track patient health data and improve outcomes? Josh Claman, CEO of medical software developer Rimidi, discusses the clinical and financial benefits of remote monitoring with Medical Economics editorial director Chris Mazzolini.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Medical Economics

Physicians finally got a Medicare raise. Keeping it is the hard part.

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

ADA ousts researchers then apologizes; Medicare Advantage reverses 95% of appealed denials; AMA takes on AI and corporate medicine — Morning Medical Update Weekly Recap

The growing role of remote patient monitoring devices

Related Content

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

Cash-only practice, with John C. Cianca, M.D., FAAPMR, president of the American Academy of Physical Medicine and Rehabilitation

‘More challenging every day’ — Advocates call for lawmakers to support independent medical practice

From spreadsheets to strategy, with Melinda Mastel, MBA, MS, of the Medical College of Wisconsin

Why where you live may matter more than how you're treated, with experts from the Physicians Foundation

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

Physicians finally got a Medicare raise. Keeping it is the hard part.

Medtronic acquires neurovascular access device maker Scientia Vascular for $550M

The new front door to health care, with Andrea Giamalva, M.D., FAAFP, of Experity

ADA ousts researchers then apologizes; Medicare Advantage reverses 95% of appealed denials; AMA takes on AI and corporate medicine — Morning Medical Update Weekly Recap

The $100,000 H-1B fee: Impact on the health care sector, legal challenge and current status